Related Experiment Videos
Studies on a new radiopaque polymeric biomaterial
1Biomaterials and Polymer Research Institute Maastricht-Eindhoven (Bioprime), University of Limburg, The Netherlands.
Biomaterials
|November 1, 1994
Summary
A novel radiopaque polymer was developed for medical applications. This new biomaterial exhibits excellent X-ray visibility and low thrombogenicity, making it suitable for advanced endovascular stents.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Medical Device Engineering
Background:
- Metallic stents have limitations including poor biocompatibility.
- There is a growing trend towards all-polymeric stents for improved patient outcomes.
- Radiopaque materials are crucial for visualizing and positioning medical devices like stents.
Purpose of the Study:
- To synthesize and characterize a novel radiopaque polymeric biomaterial.
- To evaluate the material's X-ray visibility and in vitro thrombogenicity.
- To assess the potential of this polymer for use in endovascular stents.
Main Methods:
- Terpolymer synthesis via radical polymerization of 2-(p-iodobenzoyl)-ethyl methacrylate, methyl methacrylate (MMA), and 2-hydroxyethyl methacrylate (HEMA).
- Physicochemical characterization using GPC, NMR, DSC, and contact angle measurements.
- In vitro thrombogenicity assay and scanning electron microscopy for platelet interaction studies.
Main Results:
- A new family of radiopaque polymers was successfully synthesized.
- The polymer demonstrated excellent X-ray visibility, even in thin fibers.
- The material exhibited low in vitro thrombogenicity, comparable to passive materials like PVC.
Conclusions:
- The developed radiopaque polymer shows significant promise for endovascular stent applications.
- Its properties are advantageous for use in percutaneous transluminal coronary angioplasty (PTCA).
- This biomaterial supports the shift towards more biocompatible all-polymeric stent designs.